Neoprobe licenses Alzheimer’s diagnosis imaging agent from AZN
Neoprobe (NYSE Amex:NEOP) has licensed from AstraZeneca (NYSE:AZN) the worldwide rights to an imaging drug … Continue reading Neoprobe licenses Alzheimer’s diagnosis imaging agent from AZN
0 Comments